Clinical trial / 2020
A potassium-enriched salt substitute significantly increased urinary potassium and reduced systolic blood pressure in rural China.
The Salt Substitute and Stroke Study is an ongoing 5-year cluster randomized trial evaluating potassium-enriched salt substitute versus usual salt in 20,996 individuals across 600 Chinese villages. Intermediate markers assessed over 3 years showed mean differences between the intervention and control groups of -0.32 g (95% CI: -0.68 to 0.05) for 24-hour urinary sodium, +0.77 g (+0.60 to +0.93) for 24-hour urinary potassium, and -2.65 mmHg (-4.32 to -0.97) for systolic blood pressure. Diastolic blood pressure difference was +0.30 mmHg (-0.72 to +1.32). Salt substitute use was 97.5% in the intervention group versus 4.2% in controls, and the overall annual fatal and non-fatal stroke rate across the first 2 years was 3.2%.
- Study type
- Cluster randomized trial
- Who was studied
- 20,996 individuals across 600 villages in rural China
- What was measured
- 24-hour urinary sodium and potassium, blood pressure, salt substitute use, stroke rate
THE PAPER
Interim effects of salt substitution on urinary electrolytes and blood pressure in the China Salt Substitute and Stroke Study (SSaSS).
Huang L, Tian M, Yu J, Li Q, Liu Y, Yin X, Wu JH, Marklund M, Wu Y, Li N, Elliott P, Yan LL, Labarthe DR, Hao Z, Shi J, Feng X, Zhang J, Zhang Y, Zhang R, Zhou B, Li Z, Sun J, Zhao Y, Yu Y, Neal B. Am Heart J, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.